Antihypertensive Agents Have Different Ability to Modulate Arterial Pressure and Heart Rate Variability in 2K1C Rats

American Journal of Hypertension

Volumn 19, Issue 10, 2006, Pages 1079-1083

  Nobre, Fernando ^a   da Silva, Carlos Alberto Aguiar ^a   Coelho, Eduardo Barbosa ^a   Salgado, Helio Cesar ^a   Fazan Jr , Rubens ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antihypertensive treatment; arterial pressure variability; heart rate variability; hypertension; rat

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; HYDROCHLOROTHIAZIDE; RAMIPRIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART RATE VARIABILITY; HYPERTENSION; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SPECTROSCOPY; SYSTOLIC BLOOD PRESSURE;

AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; HEART RATE; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; MALE; RAMIPRIL; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM;

EID: 33749244934     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.02.011     Document Type: Article

References (29)

1. Menezez Ada Jr. S., Moreira H.G., and Daher M.T. Analysis of heart rate variability in hypertensive patients before and after treatment with angiotensin II converting enzyme inhibitors. Arq Bras Cardiol 83 (2004) 169-172
2. Goldberger J.J. Sympathovagal balance: how should we measure it?. Am J Physiol Heart Circ Physiol 276 (1999) H1273-H1280
3. Malliani A., Pagani M., Lombardi F., and Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84 (1991) 482-492
4. Pagani M., Lombardi F., Guzzetti S., Rimoldi O., Furlan R., Pizzinelli P., Sandrone G., Malfatto G., Dell'Orto S., Piccaluga E., Turiel T., Baselli G., Cerutti S., and Malliani A. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59 (1986) 178-193
5. Miao C.Y., Shen F.M., and Su D.F. Blood pressure variability is increased in genetic hypertension and L-NAME induced hypertension. Acta Pharmacol Sin 22 (2001) 137-140
6. Su D.F., and Miao C.Y. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol 28 (2001) 709-715
7. Ponchon P., and Elghozi J.L. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one clip hypertensive rats. Eur J Pharmacol 297 (1996) 61-70
8. Xie H.H., Shen F.M., Cao Y.B., Li H.L., and Su D.F. Effects of low-dose ketanserin on blood pressure variability, baroreflex sensitivity and end-organ damage in spontaneously hypertensive rats. Clin Sci 108 (2005) 547-552
9. Parati G., Pomidossi G., Albini F., Malaspina D., and Mancia G. Relationship of 24-hour blood pressure mean and variability to severity to target-organ damage in hypertension. J Hypertens 5 (1987) 93-98
10. Cevese A., Gulli G., Polati E., Gottin L., and Grasso R. Baroreflex and oscilation of heart period at 0.1 Hz studied by α-blockade and cross spectral analysis in healthy humans. J Physiol 53 (2001) 235-244
11. Cerutti C., Barres C., and Paultre C. Baroreflex modulation of blood pressure and heart rate variabilities in rats: assessment by spectral analysis. Am J Physiol Heart Circ Physiol 266 (1994) H1993-H2000
12. Malpas S.C. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol Heart Circ Physiol 282 (2002) H6-H20
13. Ponchon P., Grichois M.L., and Elghozi J.L. Effect of losartan on short-term variability of blood pressure of renovascular hypertensive rats: a spectral study. J Hypertens 11 (1993) S244-S245
14. Ponchon P., and Elghozi J.L. Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model. Arch Mal Coeur Vaiss 88 (1995) 1203-1207
15. Rump L.C. Advantages of Ang II receptor blockade over ACE inhibition with respect suppression of sympathetic activity: heartening news for the kidney?. Nephrol Dial Transplant 14 (1999) 556-559
16. Ohlstein E.H., Brooks D.P., Feuerstein G.Z., and Ruffolo Jr. R.R. Inhibition of sympathetic outflow by angiotensin II receptor antagonist, eprosartan, but not losartan, valsartan or ibesartan: relationship to differences in prejunctional angiotensin II receptor blockade. Pharmacology 55 (1997) 244-251
17. Heusser K., Vitkovsky J., Raasch, Scmieder R.E., and Schobel H.P. Elevation of sympathetic activity by eprosartan in young male subjects. Am J Hypertens 17 (2004) 658-654
18. Montano N., Gnecchi-Ruscone T., Porta A., Lombardi F., Malliani A., and Barman S.M. Presence of vasomotor and respiratory rhythms in the discharge of single medullary neurons involved in the regulation of cardiovascular system. J Auton Nerv Syst 57 (1996) 116-112
19. Pagani M., Montano N., Porta A., Malliani A., Abboud F., Birkett C., and Somers V.K. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 95 (1997) 1441-1448
20. Jokkel G., Bonyhay I., and Kollai M. Heart rate variability after complete autonomic blockade in man. J Auton Nerv Syst 51 (1995) 85-89
21. Grasso R., Schena F., Gulli G., and Cevese A. Does low frequency variability of heart period reflect a specific parasympathetic mechanism?. J Auton Nerv Syst 63 (1997) 30-38
22. De Boer R.W., Karemaker J.M., and Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol 253 (1987) H680-H689
23. Di Rienzo M., Grassi G., Pedotti A., and Mancia G. Continuous vs. intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension 5 (1983) 264-269
24. Pickering T.G., and James G.D. Ambulatory blood pressure and prognosis. J Hypertens Suppl 12 (1994) S29-S33
25. Kikuya M., Hozawa A., Ohokubo T., Tsuji I., Michimata M., Matsubara M., Ota M., Nagai K., Araki T., Satoh H., Ito S., Hisamichi S., and Imai Y. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 36 (2000) 901-906
26. Mancia G., Parati G., Castiglioni P., Tordi R., Tortorici E., Glavina F., and Di Rienzo M. Daily life blood pressure changes are steeper in hypertensive than in normotensive subjects. Hypertension 42 (2003) 277-282
27. Lacolley P., Bezie Y., Girerd X., Challande P., Benetos A., Boutouyrie P., Ghodsi N., Lucet B., Azoui R., and Laurent S. Aortic distensibility and structural changes in sino-aortic denervated rats. Hypertension 26 (1995) 337-340
28. Mancia G., and Parati G. Importance of smooth and sustained blood pressure control in preventing cardiovascular morbidity and mortality. Blood Pressure Suppl 3 (2001) 26-32
29. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens Suppl 23 Suppl 1 (2005) S19-S25